GSK-3117391 ( CHR-5154;GSK3117391;CHR5154 )

产品货号. M10089 CAS No. 1018673-42-1

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

拼团产品询价大包装询价加入购物车

产品名称

GSK-3117391
注意事项

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
产品简述

GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor.
产品描述

GSK-3117391 (CHR-5154) is a novel macrophage-targeted HDAC inhibitor, has the potential to complement existing therapies in the treatment of chronic inflammatory disorders such as rheumatoid arthritis.Rheumatoid Arthritis Phase 2 Clinical
同义词

CHR-5154;GSK3117391;CHR5154
通路

Cell Cycle/DNA Damage
靶点

HDAC
受体

HDAC
研究领域

Inflammation/Immunology
适应症

Rheumatoid Arthritis

CAS Number

1018673-42-1
分子量

389.50
分子式

C21H31N3O4
纯度

>98% (HPLC)
溶解度

——
SMILES

O=C(OC1CCCC1)[C@H](C2CCCCC2)NCC3=CC=C(CCC(NO)=O)N=C3
化学全称

cyclopentyl (S)-2-cyclohexyl-2-((6-(3-(hydroxyamino)-3-oxopropyl)pyridin-3-yl)amino)acetate

计算器

产品手册

关联产品

PCI-34051

PCI-34051 is a potent and specific HDAC8 inhibitor with IC50 of 10 nM.
Tasquinimod

An orally active antiangiogenic agent with anti-prostate cancer activity, an allosteric modulator of HDAC4 with Kd of 10-30 nM.
Tianeptinaline

Tianeptinaline is a class I HDAC-selective, brain penetrant analogue of tianeptine with IC50 of 0.24, 0.12 and 0.155 uM for HDAC1, 2 and 3 respectively.